A Guide to Meeting Promoting Interoperability Program Requirements
As the healthcare landscape evolves, so do the requirements for quality reporting. One such significant change for hospitals and critical access hospitals (CAHs) in the upcoming year (CY 2024) is the mandatory requirement of the Antimicrobial Use and Resistance (AUR) Surveillance measure under the Public Health and Clinical Data Exchange Objective in the Medicare Promoting Interoperability (PI) Program.